Age-associated changes of islet endocrine cells and the effects of body mass index in Japanese

Journal of Diabetes Investigation

Volumn 5, Issue 1, 2014, Pages 38-47

  Mizukami, Hiroki ^a   Takahashi, Kazunori ^a   Inaba, Wataru ^a   Osonoi, Sho ^a   Kamata, Kosuke ^a   Tsuboi, Kentaro ^a   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cell turnover; Aging; Islet structure

Indexed keywords

HISTONE H2AX; KI 67 ANTIGEN; PROTEIN P16; TRANSCRIPTION FACTOR PDX 1;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; AUTOPSY; BODY MASS; CELL DENSITY; CELL PROLIFERATION; CELL VOLUME; CHILD; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; JAPANESE; MAJOR CLINICAL STUDY; MALE; MATURATION; MORPHOMETRICS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84896734750     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12118     Document Type: Article

References (40)

1. Wareham NJ. Epidemiology of type 2 diabetes. Endocrinol Nutr 2009; 56(Suppl 4): 60-62.
2. Volpato S, Maraldi C, Fellin R. Type 2 diabetes and risk for functional decline and disability in older persons. Curr Diabetes Rev 2010; 6: 134-143.
3. Sakuraba H, Mizukami H, Yagihashi N, et al. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002; 45: 85-96.
4. Butler AE, Janson J, Bonner-Weir S, et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110.
5. Yoon KH, Ko SH, Cho JH, et al. Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003; 88: 2300-2308.
6. Rahier J, Guiot Y, Goebbels RM, et al. Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10(Suppl 4): 32-42.
7. Meier JJ, Butler AE, Saisho Y, et al. β-cell replication is the primary mechanism subserving the postnatal expansion of β-cell mass in humans. Diabetes 2008; 57: 1584-1594.
8. Gregg BE, Moore PC, Demozay D, et al. Formation of a human β-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab 2012; 97: 3197-3206.
9. Saisho Y, Elashoff D, Butler AE, et al. β-Cell mass and turnover in humans. Diabetes Care 2013; 36: 111-117.
10. Malaisse WJ, Louchami K, Sener A. Noninvasive imaging of pancreatic β-cells. Nat Rev Endocrinol 2009; 5: 394-400.
11. Yagihashi S. Imaging of insulin factory: is it just imagination or approaching reality? J Diabetes Invest 2012; 3: 429-431.
12. Maedler K, Schumann DM, Schulthess F, et al. Aging correlates with decreased β-cell proliferative capacity and enhanced sensitivity to apoptosis. A potential role of Fas and pancreatic duodenal homeobox-1. Diabetes 2006; 55: 2455-2462.
13. Gannon M, Ables ET, Crawford L, et al. pdx-1 function is specifically required in embryonic β cells to generate appropriate numbers of endocrine cell types and maintain glucose homeostasis. Dev Biol 2008; 314: 406-417.
14. Elghazi L, Balcazar N, Blandino-Rosano M, et al. Decreased IRS signaling impairs β-cell cycle progression and survival in transgenic mice overexpressing S6K in beta-cells. Diabetes 2010; 59: 2390-2399.
15. Kohler CU, Olewinski M, Tannapfel A, et al. Cell cycle control of β-cell replication in the prenatal and postnatal human pancreas. Am J Physiol 2011; 300: E221-E230.
16. Soliman MA, Berardi P, Pastyryeva S, et al. ING1a expression increases during replicative senescence and induces a senescent phenotype. Aging Cell 2008; 7: 783-794.
17. Mah LJ, El-Osta A, Karagiannis TC. γH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010; 24: 679-686.
18. Mizukami H, Inaba W, Takahashi K, et al. Augmented reduction of islet β-cell mass in Goto-Kakizaki rats fed high-fat diet and its suppression by pitavastatin treatment. J Diabetes Invest 2012; 3: 235-244.
19. Inaba W, Mizukami H, Kamata K, et al. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats. Eur J Pharmacol 2012; 691: 297-306.
20. Maedler K, Schumann DM, Sauter N, et al. Low concentration of interleukin-1β induces FLICE-inhibitory protein-mediated β-cell proliferation in human pancreatic islets. Diabetes 2006; 55: 2713-2722.
21. Reers C, Erbel S, Esposito I, et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol 2009; 160: 185-191.
22. Kaneto H, Xu G, Fujii N, et al. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 2002; 277: 30010-30018.
23. Kawamori D, Kajimoto Y, Kaneto H, et al. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. Diabetes 2003; 52: 2896-2904.
24. Ebato C, Uchida T, Arakawa M, et al. Autophagy is important in islet homeostasis and compensatory increase of β cell mass in response to high-fat diet. Cell Metab 2008; 8: 325-332.
25. Ishii A, Nakamura K, Kishimoto H, et al. Telomere shortening with aging in the human pancreas. Exp Gerontol 2006; 41: 882-886.
26. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res 2009; 104: 150-158.
27. Taoufik E, Probert L. Ischemic neuronal damage. Curr Pharm Des 2008; 14: 3565-3573.
28. Vanlangenakker N, Vanden Berghe T, Krysko DV, et al. Molecular mechanisms and pathophysiology of necrotic cell death. Curr Mol Med 2008; 8: 207-220.
29. Cnop M, Hughes SJ, Igoillo-Esteve M, et al. The long lifespan and low turnover of human islet β cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 2010; 53: 321-330.
30. Maclean N, Ogilvie RF. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 1955; 4: 367-376.
31. Funakoshi S, Fujimoto S, Hamasaki A, et al. Analysis of factors influencing pancreatic β-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract 2008; 82: 353-358.
32. Oka R, Yagi K, Sakurai M, et al. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. Endocr J 2012; 59: 55-64.
33. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007; 20: 933-942.
34. Szczepaniak LS, Victor RG, Mathur R, et al. Pancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations. Diabetes Care 2012; 35: 2377-2383.
35. Kim H, Toyofuku Y, Lynn FC, et al. Serotonin regulates pancreatic β cell mass during pregnancy. Nat Med 2010; 16: 804-808.
36. Butler AE, Cao-Minh L, Galasso R, et al. Adaptive changes in pancreatic β cell fractional area and β cell turnover in human pregnancy. Diabetologia 2010; 53: 2167-2176.
37. Itoh H, Takei K. Immunohistochemical and statistical studies on the islets of Langerhans pancreas in autopsied patients after gastrectomy. Hum Pathol 2000; 31: 1368-1376.
38. De Paula AL, Stival AR, Halpern A, et al. Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms. J Gastrointest Surg 2011; 15: 1344-1353.
39. Pisania A, Weir GC, O'Neil JJ, et al. Quantitative analysis of cell composition and purity of human pancreatic islet preparations. Lab Invest 2010; 90: 1661-1675.
40. Bonner-Weir S, Li W-C, Ouziel-Yahalom L, et al. β-cell growth and regeneration: replication is only part of story. Diabetes 2010; 59: 2340-2348.